ACE and diabetes mellitus: In addition, among patients with diabetes, important comorbidities such as hypertension, heart failure (NYHA class I-II), and chronic kidney disease were more prevalent, and the rate of using antiplatelet therapy, ARBs, ACE inhibitors and beta blockers were higher.